Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: ¹⁸F-Fallypride Positron Emission Tomography Study

• Rebecca Kuepper ,

  * E-mail: r.kuepper@maastrichtuniversity.nl

  Affiliation Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands

  ⨯
• Jenny Ceccarini,

  Affiliation Division of Nuclear Medicine, University Hospital and Catholic University, Leuven, Belgium

  ⨯
• Johan Lataster,

  Affiliations Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands, Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands

  ⨯
• Jim van Os,

  Affiliations Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands, Department of Psychosis Studies, Institute of Psychiatry, King’s Health Partners, King’s College London, London, United Kingdom

  ⨯
• Marinus van Kroonenburgh,

  Affiliation Division of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands

  ⨯
• Joop M. A. van Gerven,

  Affiliation Centre for Human Drug Research, Leiden, The Netherlands

  ⨯
• Machteld Marcelis,

  Affiliation Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands

  ⨯
• Koen Van Laere,

  Affiliation Division of Nuclear Medicine, University Hospital and Catholic University, Leuven, Belgium

  ⨯
• Cécile Henquet

  Affiliations Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands, PsyQ Heerlen, Mondriaan, South Limburg, The Netherlands

  ⨯